Andrew McIntosh
Concepts (344)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 48 | 2026 | 1430 | 3.560 |
Why?
| | Schizophrenia | 23 | 2026 | 464 | 2.640 |
Why?
| | Genetic Predisposition to Disease | 41 | 2026 | 2399 | 2.530 |
Why?
| | Bipolar Disorder | 16 | 2026 | 291 | 2.520 |
Why?
| | DNA Methylation | 18 | 2026 | 690 | 1.610 |
Why?
| | Biological Specimen Banks | 15 | 2025 | 118 | 1.470 |
Why?
| | Mental Disorders | 14 | 2026 | 1169 | 1.420 |
Why?
| | Multifactorial Inheritance | 18 | 2026 | 209 | 1.360 |
Why?
| | Depression | 13 | 2025 | 1557 | 1.250 |
Why?
| | Polymorphism, Single Nucleotide | 35 | 2026 | 2181 | 1.250 |
Why?
| | Scotland | 15 | 2026 | 38 | 1.140 |
Why?
| | Antidepressive Agents | 3 | 2021 | 242 | 1.100 |
Why?
| | United Kingdom | 20 | 2025 | 358 | 1.090 |
Why?
| | Brain | 25 | 2026 | 2969 | 0.970 |
Why?
| | Neuroticism | 5 | 2019 | 19 | 0.950 |
Why?
| | Epigenesis, Genetic | 16 | 2025 | 693 | 0.780 |
Why?
| | Phenotype | 16 | 2026 | 3170 | 0.750 |
Why?
| | Brain Mapping | 7 | 2022 | 542 | 0.740 |
Why?
| | Prefrontal Cortex | 3 | 2020 | 336 | 0.700 |
Why?
| | Pregnancy Proteins | 1 | 2021 | 36 | 0.690 |
Why?
| | Antigen Presentation | 1 | 2022 | 208 | 0.650 |
Why?
| | Psychotic Disorders | 6 | 2021 | 192 | 0.640 |
Why?
| | Transcranial Magnetic Stimulation | 2 | 2015 | 67 | 0.640 |
Why?
| | Health Surveys | 2 | 2020 | 520 | 0.640 |
Why?
| | Cohort Studies | 21 | 2025 | 6032 | 0.630 |
Why?
| | Neuroimaging | 7 | 2021 | 300 | 0.630 |
Why?
| | Electronic Mail | 1 | 2020 | 60 | 0.610 |
Why?
| | Humans | 118 | 2026 | 145763 | 0.610 |
Why?
| | Magnetic Resonance Imaging | 15 | 2025 | 3915 | 0.590 |
Why?
| | Pharmacoepidemiology | 1 | 2019 | 23 | 0.580 |
Why?
| | Aging | 11 | 2025 | 1973 | 0.570 |
Why?
| | Mood Disorders | 5 | 2021 | 144 | 0.560 |
Why?
| | Drug Utilization | 1 | 2019 | 168 | 0.540 |
Why?
| | Genetic Loci | 8 | 2019 | 267 | 0.500 |
Why?
| | Adult | 53 | 2025 | 40872 | 0.490 |
Why?
| | Intelligence | 3 | 2022 | 115 | 0.490 |
Why?
| | Sex Characteristics | 6 | 2022 | 789 | 0.480 |
Why?
| | CpG Islands | 9 | 2026 | 171 | 0.480 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 2 | 2020 | 430 | 0.470 |
Why?
| | Prescription Drugs | 1 | 2017 | 111 | 0.470 |
Why?
| | Quantitative Trait Loci | 6 | 2026 | 381 | 0.470 |
Why?
| | Nerve Growth Factors | 1 | 2016 | 79 | 0.460 |
Why?
| | Synaptic Transmission | 1 | 2018 | 292 | 0.460 |
Why?
| | Male | 64 | 2026 | 73003 | 0.450 |
Why?
| | Female | 68 | 2026 | 79035 | 0.450 |
Why?
| | Memory, Short-Term | 2 | 2017 | 269 | 0.450 |
Why?
| | Epigenomics | 4 | 2025 | 117 | 0.450 |
Why?
| | Nerve Tissue Proteins | 2 | 2021 | 592 | 0.450 |
Why?
| | Middle Aged | 42 | 2025 | 36302 | 0.450 |
Why?
| | Drug Monitoring | 1 | 2019 | 401 | 0.440 |
Why?
| | Alcoholism | 6 | 2024 | 826 | 0.440 |
Why?
| | Cognition | 7 | 2024 | 1271 | 0.430 |
Why?
| | Autism Spectrum Disorder | 1 | 2020 | 423 | 0.420 |
Why?
| | Mental Health | 2 | 2022 | 796 | 0.410 |
Why?
| | Risk Factors | 18 | 2025 | 10917 | 0.410 |
Why?
| | Tumor Suppressor Proteins | 1 | 2016 | 322 | 0.400 |
Why?
| | Resilience, Psychological | 1 | 2016 | 150 | 0.400 |
Why?
| | Aged | 34 | 2025 | 26215 | 0.390 |
Why?
| | Calcium Channels | 1 | 2014 | 157 | 0.380 |
Why?
| | Transcriptome | 3 | 2026 | 1042 | 0.380 |
Why?
| | Mendelian Randomization Analysis | 3 | 2022 | 58 | 0.370 |
Why?
| | Genomics | 5 | 2025 | 830 | 0.340 |
Why?
| | Temperament | 1 | 2011 | 40 | 0.330 |
Why?
| | Human Development | 2 | 2021 | 21 | 0.320 |
Why?
| | Neurodegenerative Diseases | 3 | 2025 | 143 | 0.320 |
Why?
| | Family Health | 1 | 2011 | 191 | 0.310 |
Why?
| | Risk Assessment | 3 | 2018 | 3752 | 0.310 |
Why?
| | Educational Status | 3 | 2021 | 470 | 0.310 |
Why?
| | Marijuana Abuse | 3 | 2020 | 214 | 0.310 |
Why?
| | Chromosome Mapping | 3 | 2025 | 507 | 0.300 |
Why?
| | Longitudinal Studies | 7 | 2025 | 2967 | 0.300 |
Why?
| | Cognition Disorders | 4 | 2017 | 544 | 0.300 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2015 | 1751 | 0.280 |
Why?
| | White Matter | 3 | 2020 | 155 | 0.280 |
Why?
| | Schizophrenic Psychology | 3 | 2018 | 99 | 0.270 |
Why?
| | Genetic Markers | 3 | 2018 | 338 | 0.270 |
Why?
| | Interleukin-6 | 2 | 2025 | 779 | 0.270 |
Why?
| | Linkage Disequilibrium | 5 | 2020 | 255 | 0.260 |
Why?
| | Netrin-1 | 2 | 2018 | 17 | 0.260 |
Why?
| | Young Adult | 17 | 2025 | 14251 | 0.250 |
Why?
| | Depressive Disorder | 2 | 2022 | 374 | 0.250 |
Why?
| | Neurodevelopmental Disorders | 2 | 2022 | 229 | 0.250 |
Why?
| | Cytochrome P-450 CYP2C19 | 1 | 2026 | 27 | 0.240 |
Why?
| | DEAD-box RNA Helicases | 1 | 2026 | 84 | 0.230 |
Why?
| | Case-Control Studies | 11 | 2026 | 3634 | 0.230 |
Why?
| | Adolescent | 18 | 2025 | 22573 | 0.230 |
Why?
| | Off-Road Motor Vehicles | 1 | 2025 | 4 | 0.230 |
Why?
| | Accidents, Occupational | 1 | 2025 | 21 | 0.220 |
Why?
| | Signal Transduction | 4 | 2020 | 5223 | 0.220 |
Why?
| | Neural Pathways | 4 | 2022 | 317 | 0.220 |
Why?
| | Connectome | 2 | 2024 | 96 | 0.220 |
Why?
| | Gene Expression Regulation | 5 | 2026 | 2601 | 0.220 |
Why?
| | Genetic Variation | 4 | 2019 | 976 | 0.220 |
Why?
| | Agriculture | 1 | 2025 | 94 | 0.210 |
Why?
| | Chronic Traumatic Encephalopathy | 1 | 2024 | 18 | 0.210 |
Why?
| | Hallucinations | 1 | 2004 | 32 | 0.210 |
Why?
| | Athletic Injuries | 2 | 2024 | 573 | 0.210 |
Why?
| | Substance-Related Disorders | 3 | 2021 | 1102 | 0.210 |
Why?
| | Alcohol Drinking | 4 | 2025 | 843 | 0.200 |
Why?
| | Self Report | 4 | 2025 | 876 | 0.200 |
Why?
| | Vision Disparity | 1 | 2003 | 4 | 0.200 |
Why?
| | Anxiety Disorders | 3 | 2021 | 371 | 0.200 |
Why?
| | Genome, Human | 2 | 2024 | 422 | 0.200 |
Why?
| | Safety | 1 | 2025 | 358 | 0.190 |
Why?
| | Health Status | 2 | 2019 | 835 | 0.190 |
Why?
| | Aged, 80 and over | 9 | 2025 | 8346 | 0.190 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2016 | 2602 | 0.180 |
Why?
| | Genetic Association Studies | 3 | 2019 | 371 | 0.180 |
Why?
| | Aging, Premature | 1 | 2022 | 17 | 0.180 |
Why?
| | Image Processing, Computer-Assisted | 5 | 2018 | 782 | 0.180 |
Why?
| | Craniocerebral Trauma | 1 | 2024 | 179 | 0.180 |
Why?
| | Photic Stimulation | 1 | 2003 | 264 | 0.180 |
Why?
| | Cerebral Small Vessel Diseases | 1 | 2021 | 6 | 0.180 |
Why?
| | Netherlands | 1 | 2021 | 84 | 0.180 |
Why?
| | Logistic Models | 4 | 2024 | 2139 | 0.170 |
Why?
| | Birth Weight | 2 | 2021 | 517 | 0.170 |
Why?
| | Patient Selection | 1 | 2025 | 739 | 0.170 |
Why?
| | Chronic Pain | 2 | 2017 | 292 | 0.170 |
Why?
| | Socioeconomic Factors | 2 | 2024 | 1327 | 0.160 |
Why?
| | Diabetes Mellitus | 2 | 2022 | 1101 | 0.160 |
Why?
| | Biological Variation, Population | 1 | 2020 | 21 | 0.160 |
Why?
| | Prevalence | 4 | 2024 | 2874 | 0.160 |
Why?
| | Internet | 1 | 2025 | 693 | 0.160 |
Why?
| | Brain Concussion | 2 | 2020 | 646 | 0.160 |
Why?
| | Biomarkers | 6 | 2025 | 4302 | 0.160 |
Why?
| | Cerebral Cortex | 2 | 2021 | 474 | 0.160 |
Why?
| | Immune System | 1 | 2021 | 180 | 0.160 |
Why?
| | Life Change Events | 2 | 2024 | 147 | 0.160 |
Why?
| | Australia | 4 | 2025 | 291 | 0.150 |
Why?
| | Cross-Sectional Studies | 7 | 2025 | 5922 | 0.150 |
Why?
| | Genomic Imprinting | 1 | 2019 | 27 | 0.150 |
Why?
| | Comorbidity | 4 | 2017 | 1662 | 0.150 |
Why?
| | Mortality, Premature | 1 | 2019 | 15 | 0.150 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2018 | 36 | 0.140 |
Why?
| | Mortality | 2 | 2018 | 380 | 0.140 |
Why?
| | Psychiatric Status Rating Scales | 4 | 2018 | 533 | 0.140 |
Why?
| | Child | 9 | 2025 | 22739 | 0.140 |
Why?
| | Cerebrovascular Disorders | 1 | 2019 | 105 | 0.140 |
Why?
| | Genotype | 5 | 2026 | 1857 | 0.140 |
Why?
| | Risk | 6 | 2020 | 923 | 0.140 |
Why?
| | Longevity | 1 | 2019 | 178 | 0.130 |
Why?
| | Linear Models | 4 | 2019 | 849 | 0.130 |
Why?
| | Suicide | 1 | 2025 | 729 | 0.130 |
Why?
| | Premature Birth | 1 | 2022 | 390 | 0.130 |
Why?
| | Feeding and Eating Disorders | 1 | 2020 | 165 | 0.130 |
Why?
| | Sports | 1 | 2020 | 212 | 0.130 |
Why?
| | Substantia Nigra | 1 | 2017 | 64 | 0.130 |
Why?
| | Diagnostic Self Evaluation | 1 | 2017 | 24 | 0.130 |
Why?
| | Molecular Epidemiology | 1 | 2017 | 74 | 0.130 |
Why?
| | International Classification of Diseases | 1 | 2018 | 150 | 0.130 |
Why?
| | Proteome | 1 | 2022 | 513 | 0.130 |
Why?
| | Ventral Tegmental Area | 1 | 2017 | 63 | 0.120 |
Why?
| | Mechanotransduction, Cellular | 1 | 2018 | 121 | 0.120 |
Why?
| | Headache | 1 | 2018 | 151 | 0.120 |
Why?
| | Angina Pectoris | 1 | 2017 | 76 | 0.120 |
Why?
| | Age Distribution | 1 | 2017 | 404 | 0.120 |
Why?
| | Functional Neuroimaging | 2 | 2017 | 61 | 0.120 |
Why?
| | C-Reactive Protein | 1 | 2018 | 423 | 0.120 |
Why?
| | Birth Order | 1 | 2016 | 14 | 0.120 |
Why?
| | Character | 1 | 2016 | 3 | 0.120 |
Why?
| | Cannabis | 1 | 2003 | 510 | 0.120 |
Why?
| | Gyrus Cinguli | 1 | 2016 | 97 | 0.120 |
Why?
| | Maternal Age | 1 | 2016 | 128 | 0.120 |
Why?
| | Apolipoprotein E4 | 1 | 2016 | 42 | 0.120 |
Why?
| | Glucocorticoids | 1 | 2020 | 532 | 0.120 |
Why?
| | DNA Copy Number Variations | 1 | 2016 | 188 | 0.110 |
Why?
| | Facial Expression | 1 | 2016 | 75 | 0.110 |
Why?
| | Mental Health Services | 1 | 2021 | 475 | 0.110 |
Why?
| | Drug Prescriptions | 1 | 2017 | 288 | 0.110 |
Why?
| | Affect | 1 | 2018 | 321 | 0.110 |
Why?
| | NF-kappa B | 1 | 2018 | 667 | 0.110 |
Why?
| | Smoking Cessation | 1 | 2018 | 441 | 0.110 |
Why?
| | Synapses | 1 | 2018 | 439 | 0.100 |
Why?
| | Regression Analysis | 3 | 2011 | 1001 | 0.100 |
Why?
| | Inflammation | 3 | 2022 | 2883 | 0.100 |
Why?
| | Cause of Death | 1 | 2016 | 471 | 0.100 |
Why?
| | Self Concept | 1 | 2016 | 254 | 0.100 |
Why?
| | Pain | 1 | 2019 | 791 | 0.100 |
Why?
| | Circadian Rhythm | 1 | 2018 | 513 | 0.100 |
Why?
| | Databases, Factual | 2 | 2017 | 1491 | 0.100 |
Why?
| | Coronary Artery Disease | 2 | 2017 | 750 | 0.100 |
Why?
| | Anisotropy | 1 | 2013 | 74 | 0.100 |
Why?
| | Diffusion Tensor Imaging | 3 | 2020 | 78 | 0.090 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2012 | 22 | 0.090 |
Why?
| | Incidence | 1 | 2019 | 2933 | 0.090 |
Why?
| | Alleles | 3 | 2022 | 896 | 0.090 |
Why?
| | Hippocampus | 3 | 2015 | 973 | 0.090 |
Why?
| | Smoking | 1 | 2018 | 1477 | 0.080 |
Why?
| | Echo-Planar Imaging | 1 | 2011 | 24 | 0.080 |
Why?
| | Hypertension | 2 | 2017 | 1276 | 0.080 |
Why?
| | Reaction Time | 3 | 2018 | 434 | 0.080 |
Why?
| | Personality Inventory | 1 | 2011 | 134 | 0.080 |
Why?
| | Mutation | 1 | 2022 | 4090 | 0.080 |
Why?
| | Neuropsychological Tests | 3 | 2018 | 1137 | 0.080 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 2 | 2018 | 232 | 0.080 |
Why?
| | Organ Size | 2 | 2025 | 461 | 0.080 |
Why?
| | Cerebral Ventricles | 1 | 2010 | 56 | 0.080 |
Why?
| | Alzheimer Disease | 1 | 2016 | 630 | 0.070 |
Why?
| | DiGeorge Syndrome | 1 | 2009 | 35 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3416 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2191 | 0.070 |
Why?
| | Skull | 2 | 2015 | 163 | 0.070 |
Why?
| | Meta-Analysis as Topic | 3 | 2015 | 173 | 0.070 |
Why?
| | Head Protective Devices | 2 | 2020 | 26 | 0.070 |
Why?
| | Disease Susceptibility | 1 | 2010 | 344 | 0.070 |
Why?
| | Stress, Psychological | 1 | 2016 | 1149 | 0.070 |
Why?
| | Rest | 2 | 2018 | 126 | 0.070 |
Why?
| | Life Style | 2 | 2022 | 486 | 0.070 |
Why?
| | Head | 2 | 2020 | 123 | 0.060 |
Why?
| | Memory | 3 | 2017 | 297 | 0.060 |
Why?
| | Europe | 2 | 2018 | 421 | 0.060 |
Why?
| | Treatment Outcome | 2 | 2022 | 11793 | 0.060 |
Why?
| | Arthritis, Rheumatoid | 1 | 2015 | 1180 | 0.060 |
Why?
| | Neoplasms | 1 | 2022 | 2913 | 0.060 |
Why?
| | Behavior | 1 | 2006 | 90 | 0.060 |
Why?
| | Prospective Studies | 4 | 2022 | 8075 | 0.060 |
Why?
| | Gene Expression Profiling | 2 | 2026 | 1777 | 0.060 |
Why?
| | Utah | 1 | 2025 | 80 | 0.060 |
Why?
| | Personal Protective Equipment | 1 | 2025 | 58 | 0.060 |
Why?
| | Sweden | 1 | 2025 | 115 | 0.060 |
Why?
| | Biomechanical Phenomena | 2 | 2020 | 860 | 0.050 |
Why?
| | Atrophy | 1 | 2025 | 199 | 0.050 |
Why?
| | Anxiety | 2 | 2022 | 1122 | 0.050 |
Why?
| | Uganda | 1 | 2024 | 90 | 0.050 |
Why?
| | Causality | 1 | 2024 | 127 | 0.050 |
Why?
| | Canada | 1 | 2025 | 432 | 0.050 |
Why?
| | Saliva | 1 | 2025 | 249 | 0.050 |
Why?
| | Models, Genetic | 1 | 2026 | 527 | 0.050 |
Why?
| | Gene Regulatory Networks | 1 | 2026 | 318 | 0.050 |
Why?
| | Surveys and Questionnaires | 3 | 2025 | 6085 | 0.050 |
Why?
| | Social Media | 1 | 2025 | 167 | 0.050 |
Why?
| | Pregnancy | 3 | 2022 | 7215 | 0.050 |
Why?
| | Cost-Benefit Analysis | 1 | 2025 | 644 | 0.050 |
Why?
| | Diagnosis, Differential | 1 | 2026 | 1512 | 0.040 |
Why?
| | Molecular Biology | 1 | 2022 | 58 | 0.040 |
Why?
| | Family | 2 | 2017 | 685 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2004 | 610 | 0.040 |
Why?
| | Suicide, Attempted | 1 | 2025 | 426 | 0.040 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2021 | 64 | 0.040 |
Why?
| | Cytoskeletal Proteins | 1 | 2022 | 157 | 0.040 |
Why?
| | Sulfurtransferases | 1 | 2021 | 10 | 0.040 |
Why?
| | Africa | 1 | 2021 | 119 | 0.040 |
Why?
| | Exome | 1 | 2022 | 229 | 0.040 |
Why?
| | Nerve Net | 1 | 2024 | 286 | 0.040 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 109 | 0.040 |
Why?
| | Communicable Disease Control | 1 | 2021 | 86 | 0.040 |
Why?
| | Age Factors | 2 | 2020 | 3346 | 0.040 |
Why?
| | Receptors, Immunologic | 1 | 2021 | 209 | 0.040 |
Why?
| | Acceleration | 1 | 2020 | 33 | 0.040 |
Why?
| | Policy | 1 | 2021 | 149 | 0.040 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 229 | 0.040 |
Why?
| | Genome | 1 | 2022 | 305 | 0.040 |
Why?
| | Polyesters | 1 | 2020 | 76 | 0.040 |
Why?
| | Chromosomes, Human, X | 1 | 2019 | 77 | 0.040 |
Why?
| | Microglia | 1 | 2022 | 273 | 0.040 |
Why?
| | Cognitive Dysfunction | 1 | 2025 | 468 | 0.040 |
Why?
| | Chromosome Duplication | 1 | 2018 | 6 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2022 | 426 | 0.040 |
Why?
| | Granulocytes | 1 | 2018 | 82 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2110 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 2018 | 165 | 0.040 |
Why?
| | Systems Biology | 1 | 2019 | 68 | 0.030 |
Why?
| | Plasma Cells | 1 | 2018 | 80 | 0.030 |
Why?
| | Community Health Planning | 1 | 2018 | 37 | 0.030 |
Why?
| | Chromosomes, Human | 1 | 2018 | 44 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2019 | 291 | 0.030 |
Why?
| | F-Box Proteins | 1 | 2018 | 24 | 0.030 |
Why?
| | Death | 1 | 2019 | 132 | 0.030 |
Why?
| | Tobacco Use Disorder | 1 | 2020 | 217 | 0.030 |
Why?
| | Brain Chemistry | 1 | 2018 | 120 | 0.030 |
Why?
| | Event-Related Potentials, P300 | 1 | 2017 | 17 | 0.030 |
Why?
| | Endophenotypes | 1 | 2017 | 23 | 0.030 |
Why?
| | Berlin | 1 | 2017 | 2 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2018 | 194 | 0.030 |
Why?
| | Nonlinear Dynamics | 1 | 2017 | 93 | 0.030 |
Why?
| | Abnormalities, Multiple | 1 | 2018 | 199 | 0.030 |
Why?
| | Oncogene Protein v-akt | 1 | 2016 | 24 | 0.030 |
Why?
| | Intellectual Disability | 1 | 2018 | 179 | 0.030 |
Why?
| | Organoids | 1 | 2018 | 144 | 0.030 |
Why?
| | Research Design | 1 | 2023 | 1139 | 0.030 |
Why?
| | Quantitative Trait, Heritable | 1 | 2017 | 114 | 0.030 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2018 | 194 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2017 | 428 | 0.030 |
Why?
| | Denmark | 1 | 2016 | 51 | 0.030 |
Why?
| | Diseases in Twins | 1 | 2017 | 116 | 0.030 |
Why?
| | Fanconi Anemia Complementation Group Proteins | 1 | 2016 | 7 | 0.030 |
Why?
| | Mental Status and Dementia Tests | 1 | 2016 | 27 | 0.030 |
Why?
| | Temporal Lobe | 2 | 2006 | 107 | 0.030 |
Why?
| | Adaptation, Psychological | 1 | 2021 | 719 | 0.030 |
Why?
| | Child, Preschool | 2 | 2022 | 11868 | 0.030 |
Why?
| | Cognitive Aging | 1 | 2016 | 19 | 0.030 |
Why?
| | Twins | 1 | 2017 | 152 | 0.030 |
Why?
| | Gene Ontology | 1 | 2016 | 54 | 0.030 |
Why?
| | Congresses as Topic | 1 | 2017 | 224 | 0.030 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2018 | 273 | 0.030 |
Why?
| | Bayes Theorem | 1 | 2017 | 421 | 0.030 |
Why?
| | Sports Medicine | 1 | 2017 | 119 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1547 | 0.030 |
Why?
| | Caudate Nucleus | 1 | 2015 | 22 | 0.030 |
Why?
| | Putamen | 1 | 2015 | 23 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2017 | 259 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2018 | 1330 | 0.030 |
Why?
| | Heterozygote | 1 | 2016 | 314 | 0.030 |
Why?
| | Gene Frequency | 1 | 2016 | 489 | 0.030 |
Why?
| | Executive Function | 1 | 2019 | 470 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 877 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 383 | 0.030 |
Why?
| | Pain Measurement | 1 | 2017 | 562 | 0.030 |
Why?
| | Haplotypes | 1 | 2016 | 500 | 0.030 |
Why?
| | Gene-Environment Interaction | 1 | 2015 | 180 | 0.030 |
Why?
| | Stem Cells | 1 | 2018 | 630 | 0.030 |
Why?
| | Inheritance Patterns | 1 | 2013 | 45 | 0.020 |
Why?
| | Athletes | 1 | 2017 | 425 | 0.020 |
Why?
| | Imaging, Three-Dimensional | 1 | 2017 | 583 | 0.020 |
Why?
| | Gene Expression | 1 | 2018 | 1478 | 0.020 |
Why?
| | Genetic Heterogeneity | 1 | 2013 | 66 | 0.020 |
Why?
| | Oxygen | 1 | 2018 | 981 | 0.020 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2013 | 65 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2018 | 740 | 0.020 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2018 | 923 | 0.020 |
Why?
| | Dementia | 1 | 2017 | 328 | 0.020 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2018 | 1146 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2014 | 463 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2018 | 2514 | 0.020 |
Why?
| | Alcohol-Induced Disorders, Nervous System | 1 | 2010 | 7 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2022 | 6464 | 0.020 |
Why?
| | Parkinson Disease | 1 | 2016 | 601 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 910 | 0.020 |
Why?
| | Crohn Disease | 1 | 2013 | 260 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2865 | 0.020 |
Why?
| | Neurons | 1 | 2018 | 1652 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2015 | 1166 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2016 | 2933 | 0.020 |
Why?
| | United States | 1 | 2025 | 16123 | 0.020 |
Why?
| | Prognosis | 1 | 2016 | 4329 | 0.020 |
Why?
| | Pilot Projects | 1 | 2013 | 1897 | 0.020 |
Why?
| | Thalamic Nuclei | 1 | 2006 | 10 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2016 | 5428 | 0.020 |
Why?
| | Apoptosis | 1 | 2015 | 2443 | 0.010 |
Why?
| | Verbal Learning | 1 | 2006 | 72 | 0.010 |
Why?
| | Amygdala | 1 | 2006 | 200 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 17325 | 0.010 |
Why?
| | Registries | 1 | 2013 | 2410 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2006 | 2123 | 0.010 |
Why?
|
|
McIntosh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|